Libra Infusions Limited (DSE:LIBRAINFU)

Bangladesh · Delayed Price · Currency is BDT

645.90

-0.80 (-0.12%)

At close: Jul 6, 2026

-18.61% (1Y)

Market Cap	1.46B -15.0%
Revenue (ttm)	197.03M -19.6%
Net Income	1.58M -68.2%
EPS	0.70 -68.2%
Shares Out	2.25M
PE Ratio	919.70
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,149
Open	n/a
Previous Close	646.70
Day's Range	642.60 - 650.90
52-Week Range	547.10 - 850.00
Beta	-0.34
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Libra Infusions

Libra Infusions Limited manufactures and sells intravenous fluids in Bangladesh. Its products are used in medical situations, including diarrhoeal disease, surgical operation, loss of blood, weakness, and hospitalization. The company offers LIBOTT, LIBOTT-10, LIBOTT-25, LIBOTT-S, LIBOTT-S JR, NORMASOL, BABY SALINE, DIASOL, HARTSOL, LIBRAZOL, LIBRACIN, LIBOTT-M, LIBRACIN-400, and LIBRET products. The company was formerly known as Libra Pharmaceutical Limited and changed its name to Libra Infusions Limited in 1999. Libra Infusions Limited was inc... [Read more]

Industry Pharmaceutical Preparations

Founded 1976

Employees 699

Stock Exchange Dhaka Stock Exchange

Ticker Symbol LIBRAINFU

Full Company Profile